Home > News
News
1.Anaxomics to be present at Chicago 2010 Bio International Convention in May 3-6
"BIO represents more than 1,200 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products."
For more info: Convention.bio.org/
2. Recent publishing by Anaxomics Scientific Board
Pujol A., Mosca R., Farrés J & Aloy P.:
Unveiling the role of network and systems biology in drug discovery.
Trends Pharmacol Sci. 2010 Mar;31(3):115-123
"Network and systems biology offer a novel way of approaching drug discovery by developing models that consider the global physiological environment of protein targets, and the effects of modifying them, without losing the key molecular details. Here we review some recent advances in network and systems biology applied to human health, and discuss how they can have a big impact on some of the most interesting areas of drug discovery." (...)
Pache R.A., Zanzoni A., Naval J., Mas, J.M & Aloy P. :
Towards a molecular characterisation of pathological pathways.
FEBS Lett. 2008 Apr 9; 582(8):1259-65
"The dominant conceptual reductionism in drug discovery has resulted in many promising drug candidates to fail during the last clinical phases, mainly due to a lack of knowledge about the patho-physiological pathways they are acting on." (...)
3. Anaxomics in partnership with Iridessa, a Swiss Modelling and Simulation Consultancy Firm
Iredessa provides drug development consulting services spanning from discovery through to early proof-of-concept studies. We work collaboratively with clients to deliver enhanced drug development decision making with the potential for faster time to market and/or lower development costs. The primary goals of an Iredessa collaboration typically involve one or more of the following:
To optimize the design and execution of development program(s) for one or more candidate therapeutic agent(s)- To facilitate out/in-licensing discussions with potential business partners
- To support ongoing interactions with regulatory authorities
For more info: partnerships
4. Anaxomics has been awarded the cover page of November issue of Nature Chem Biol
"Chemical tools are increasingly important for probing and manipulating complex biological systems, and systems-based approaches are a powerful way to understand the often pleiotropic biological effects of small molecules. In this issue we feature a collection of articles that highlight the emerging interface of chemical biology and systems biology. The cover shows an artistic representation of the human interactome built with the network analysis package AxPathBuilder."
November 2008
For more info: www.nature.com
5. Tras los planos de la vida
"Durante siglos, biólogos y fisiólogos estudiaron la gran diversidad de especies y organismos de la Tierra sin saber nada acerca de su composición molecular. No fue hasta mediados del siglo XIX cuando dos científicos alemanes descubrieron que plantas y animales estaban compuestos por células. Paralelamente, avances en diversos ámbitos de la química hallaron el modo de descomponer estas células en sus partes básicas."
June 14th, 2008
For more info and to download the .pdf document: El País: Tras los planos de la vida
